PeptiDream Inc a public Kanagawa, Japan-based biopharmaceutical companytoday announced that they have entered into a Research Collaboration and License Agreement with US-based Eli Lilly and Company (Lilly) focused on the discovery and development of novel peptide drug conjugates (
